CYBIN INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.310 USD | -0.64% |
|
-5.16% | +5.71% |
| 08:46pm | Cybin Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 | CI |
| Jan. 15 | Cybin, Segal Trials Collaborate to Advance Major Depressive Disorder Treatment | MT |
Chart calendar Cybin Inc.
3cea76f096eb.K2hl1x3uzxBBpxj3HGnuw-4dl_knMT1hfr8vRivJXwM.UiM8oVrXpFYM0Ha0aiK2gN181pIQcHQvTvZ_KW6Ka29yGVOCf6mDfgeWIA~81aef586b8cf374f0101f4d4d7d52651
Upcoming events on Cybin Inc.
Past events on Cybin Inc.
| 2025-01-13 11:30 am | Lytham Partners Investor Healthcare Summit |
| 2024-12-11 11:00 am | Water Tower Research Conference |
| 2024-12-07 | American College of Neuropsychopharmacology Meeting - Poster No: M59 |
| 2024-12-07 | American College of Neuropsychopharmacology Meeting - Poster No: M77 |
| 2024-11-18 08:00 am | CYB003 12-Month Phase 2 Data Call |
| 2024-11-13 04:30 pm | Milken Institute Future of Health Summit |
| 2024-11-13 07:30 am | Q2 2025 Earnings Release |
| 2024-10-08 03:00 pm | Water Tower Research Conference - Fireside Chat |
| 2024-09-26 10:00 am | TD Cowen Novel Mechanisms in Neuropsychiatry Summit |
| 2024-09-10 03:00 pm | H.C. Wainwright Global Investment Conference - Panel |
| 2024-09-09 08:30 am | H.C. Wainwright Global Investment Conference - Fireside Chat |
| 2024-08-27 10:00 am | Annual General Meeting |
| 2024-08-13 02:00 pm | CG Growth Conference |
| 2024-08-08 07:36 am | Q1 2025 Earnings Release |
| 2024-07-05 04:20 am | Interdisciplinary Psychedelic Research Conference - Panel |
| 2024-06-27 07:00 am | H.C. Wainwright Neuro Perspectives Virtual Conference |
| 2024-06-26 07:41 am | Q4 2024 Earnings Release |
| 2024-06-08 08:20 am | Interdisciplinary Psychedelic Research Conference - Panel |
| 2024-06-06 08:40 am | Interdisciplinary Psychedelic Research Conference |
| 2024-06-05 04:20 am | Interdisciplinary Psychedelic Research Conference - Panel |
Annual results
| Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 250 |
|
EBITDA Million CAD | Released Forecast Spread | -45,6 -42,6 -7.06% | -46,6 -43,7 -6.71% | -78,4 -67,4 -16.42% | -121 | -103 | -113 |
|
EBIT Million CAD | Released Forecast Spread | -63,8 -59,3 -7.64% | -51,5 -50,8 -1.43% | -78,8 -68,9 -14.4% | -137 | -149 | -120 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -67,6 -59,2 -14.29% | -47,5 -47,0 -0.97% | -78,1 -74,7 -4.54% | -144 | -170 | -90,6 |
|
Net income Million CAD | Released Forecast Spread | -67,6 -63,9 -5.89% | -47,5 -46,7 -1.72% | -78,1 -74,5 -4.75% | -138 | -170 | -90,6 |
|
EPS CAD | Released Forecast Spread | -15,2 -14,1 -8.11% | -9,88 -9,06 -9.09% | -9,50 -8,99 -5.63% | -4,87 | -6,37 | -3,49 |
| Announcement Date | 22/06/22 | 27/06/23 | 26/06/24 | - |
Quarterly results
| Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -12,6 -12,8 1.27% | -13,8 -12,7 -9.4% | -26,9 -13,6 -97.66% | -25,1 -14,0 -79.59% | -20,2 -17,8 -13.37% | -58,1 -18,4 -216.04% | -31,2 -21,5 -45.3% | -23,4 | -23,3 | -24,3 | -25,5 | -27,1 |
|
EBIT Million CAD | Released Forecast Spread | -12,7 -13,0 2.49% | -13,9 -12,7 -9.56% | -27,0 -13,8 -95.71% | -25,2 -18,0 -40.02% | -20,3 -20,9 2.99% | -58,3 -19,5 -198.65% | -31,3 -30,6 -2.37% | -33,1 | -39,7 | -41,6 | -43,7 | -46,2 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -14,5 -12,6 -15.36% | -11,9 -12,2 2.81% | -30,3 -14,0 -116.21% | -21,3 -18,0 -18.81% | -14,8 -20,0 25.85% | -57,2 -19,1 -199.81% | -10,5 -34,7 69.66% | -36,9 | -39,3 | -41,3 | -43,6 | -46,1 |
|
Net income Million CAD | Released Forecast Spread | -14,5 -12,8 -13.82% | -11,9 -12,2 2.81% | -30,3 -14,0 -116.21% | -21,3 -18,4 -16.31% | -14,8 -20,0 25.85% | -57,2 -19,1 -199.81% | -10,5 -34,7 69.66% | -36,9 | -39,3 | -41,3 | -43,6 | -46,1 |
|
EPS CAD | Released Forecast Spread | -2,66 -2,22 -20% | -1,90 -1,90 0% | -3,42 -1,37 -150% | -0,76 -1,58 52% | -0,76 -1,33 42.86% | -2,86 -0,96 -198.95% | -0,53 -1,72 69.25% | -1,45 | -1,54 | -1,60 | -1,67 | -1,55 |
| Announcement Date | 14/08/23 | 14/11/23 | 14/02/24 | 26/06/24 | 08/08/24 | 13/11/24 | 11/02/25 | - | - | - | - | - |
| Today 04:05 pm | EXELIXIS, INC.: Q4 2024 Earnings Release |
| 2025-02-12 07:30 am | ANAVEX LIFE SCIENCES CORP.: Q1 2025 Earnings Release |
| 2025-02-12 11:00 am | GENMAB A/S: Q4 2024 Earnings Release |
| 2025-02-12 04:01 pm | ASCENDIS PHARMA A/S: Q4 2024 Earnings Release |
| 2025-02-12 | AGIOS PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 2025-02-12 | ULTRAGENYX PHARMACEUTICAL INC.: Q4 2024 Earnings Release |
| 2025-02-12 | PROTHENA CORPORATION PLC: Q4 2024 Earnings Release (Projected) |
| 2025-02-12 | PEPTIDREAM INC.: Q4 2024 Earnings Release |
| 2025-02-18 | BIOCRYST PHARMACEUTICALS, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-19 08:00 am | KRYSTAL BIOTECH, INC.: Q4 2024 Earnings Release |
Past sector events for Cybin Inc.
| Today | ARVINAS, INC.: Q4 2024 Earnings Release |
| 2025-02-10 04:30 pm | ARROWHEAD PHARMACEUTICALS, INC.: Q1 2025 Earnings Release |
| 2025-02-10 04:01 pm | VERTEX PHARMACEUTICALS INCORPORATED: Q4 2024 Earnings Release |
| 2025-02-07 02:27 am | LUMOSA THERAPEUTICS CO., LTD.: January 2025 Sales and Revenue Release |
| 2025-02-07 02:07 am | TAIMED BIOLOGICS INC.: January 2025 Sales and Revenue Release |
| 2025-02-06 04:00 pm | NEUROCRINE BIOSCIENCES, INC.: Q4 2024 Earnings Release |
| 2025-02-05 04:05 pm | VIKING THERAPEUTICS, INC.: Q4 2024 Earnings Release |
| 2025-02-05 05:42 am | PHARMAESSENTIA CORPORATION: January 2025 Sales and Revenue Release |
| 2025-02-04 06:30 am | REGENERON PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 2025-01-30 07:57 pm | CLARITY PHARMACEUTICALS LTD: December 2024 Sales and Revenue Release - Activities Report |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CLXPF Stock
- Calendar Cybin Inc.